Core Alternative Capital Sells 4,562 Shares of Procter & Gamble Company (The) $PG

Core Alternative Capital lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 11.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,839 shares of the company’s stock after selling 4,562 shares during the period. Procter & Gamble accounts for 1.5% of Core Alternative Capital’s portfolio, making the stock its 24th largest holding. Core Alternative Capital’s holdings in Procter & Gamble were worth $5,199,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of PG. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Corundum Trust Company INC acquired a new position in Procter & Gamble during the 3rd quarter valued at $32,000. Mid American Wealth Advisory Group Inc. bought a new stake in Procter & Gamble in the 2nd quarter valued at $34,000. RMG Wealth Management LLC acquired a new stake in Procter & Gamble in the 2nd quarter worth $37,000. Finally, Marquette Asset Management LLC bought a new position in shares of Procter & Gamble during the 3rd quarter worth about $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G is pushing a “Supply Chain 3.0” program (AI, automation, digital tools) expected to boost efficiency, lower costs and support margin expansion — a structural positive for future profitability. Is PG’s Supply Chain 3.0 Redefining Efficiency Through Automation?
• Positive Sentiment: P&G’s contrarian strategy in China’s baby-care market is gaining traction, supporting organic revenue recovery in a key emerging market. Fewer Babies, Higher Sales: P&G’s Contrarian Bet in China Is Working
• Positive Sentiment: The company confirmed its quarterly dividend (annualized ~$4.23; ~2.8% yield), which supports income-oriented investor demand and the “total return” case. Procter & Gamble stock page
• Positive Sentiment: Some brokers have nudged targets/rating higher (recent raised targets/Overweight calls), providing incremental bullish analyst support. Procter & Gamble (NYSE:PG) Price Target Raised to $157.00
• Neutral Sentiment: Goldman Sachs kept a Hold rating (reflecting solid fundamentals but limited near-term upside), which keeps professional opinion mixed. Procter & Gamble: Solid Fundamentals but Limited Near-Term Upside Support a Hold Rating
• Neutral Sentiment: Elevated retail/investor attention and media coverage can boost volume and volatility short-term but don’t necessarily change fundamentals. Procter & Gamble Company (The) (PG) is Attracting Investor Attention
• Neutral Sentiment: P&G insiders made no new 10b5‑1 plans in Q4 2025 — signals stability but reduces forward visibility into expected insider trades. P&G Insiders Make No New 10b5-1 Trading Plans in Q4 2025
• Negative Sentiment: A senior insider (Marc S. Pritchard) sold ~95,903 shares (~$14.5M at ~$151.15), cutting his stake materially — large insider sales can sap sentiment and add short-term selling pressure. Procter & Gamble (NYSE:PG) Insider Sells $14,495,738.45 in Stock
• Negative Sentiment: UBS trimmed its price target (cut to $161) despite keeping a favorable opinion, signaling a more cautious near-term view that can weigh on upside expectations. UBS Sees a Challenging Backdrop for Procter & Gamble (PG)

Procter & Gamble Price Performance

Shares of PG stock opened at $148.49 on Wednesday. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $179.99. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.48. The firm’s 50 day moving average is $144.83 and its 200-day moving average is $150.37. The firm has a market capitalization of $345.09 billion, a price-to-earnings ratio of 22.00, a PEG ratio of 4.96 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last released its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.10% and a net margin of 19.30%.The company had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter in the previous year, the company posted $1.88 earnings per share. The firm’s quarterly revenue was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, January 23rd. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.67%.

Insiders Place Their Bets

In related news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the sale, the chief accounting officer owned 979 shares of the company’s stock, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Marc S. Pritchard sold 95,903 shares of the firm’s stock in a transaction dated Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the sale, the insider directly owned 182,607 shares in the company, valued at approximately $27,601,048.05. This represents a 34.43% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 96,629 shares of company stock valued at $14,604,323. 0.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have commented on PG shares. Wells Fargo & Company raised their price objective on Procter & Gamble from $158.00 to $165.00 and gave the stock an “overweight” rating in a research report on Friday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 29th. Barclays set a $155.00 price target on shares of Procter & Gamble in a report on Friday, January 16th. TD Cowen downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and raised their price objective for the stock from $150.00 to $156.00 in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Thirteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $167.00.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.